Primers, primer combinations, kits and their applications

A technology for kits and compositions, applied in the field of kits and their applications, primers, and primer combinations, can solve problems such as sensitivity and specificity affecting amplification

Active Publication Date: 2019-05-17
NANJING SIMCERE MEDICAL LAB CO LTD +3
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, in actual operation, it is found that due to factors such as interference between multiple primers, the non-specific amplification generated seriously affects the sensitivity and specificity of amplification.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Primers, primer combinations, kits and their applications
  • Primers, primer combinations, kits and their applications
  • Primers, primer combinations, kits and their applications

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 115

[0124] Example 1 Construction of 15 mutant plasmids

[0125] (1) Amplify the NPM1 fragment containing the insertion mutation: in such as Figure 5 Design primers at both ends of the shown insert fragments, design bidirectional primers containing deletion mutation fragments at the mutation site, and use bridge PCR to construct NPM1 fragments containing insertion mutations;

[0126] (2) Ligation and transformation reactions: use a commercial kit to connect the NPM1 mutant fragment and the PMD19-T vector and transform it into DH5α Escherichia coli;

[0127] (3) Pick positive clones and preserve species: Spread Escherichia coli on LB agarose medium containing ampicillin and culture overnight at 37°C, pick a single colony, and use the two-terminal specificity markers in the insert to select a part of them. Amplify with primers, and the cloned colonies that can amplify the target band size are sent to be sequenced and confirmed as positive, and then stored with 25% glycerol at -20°...

Embodiment 2

[0130] Embodiment 2 utilizes each primer to detect the specificity of each mutant separately

[0131] grouping:

[0132] Experimental group: 15 mutated plasmids constructed in Example 1;

[0133] The negative control is wild-type NPM1; the blank control is water.

[0134] (1) Plasmid dilution: Dilute wild-type (WT), typeA, typeB, typeD, typeDD1, typeE mutant NPM1 plasmids to 2.7x10 5 copies / uL.

[0135](2) Real-time PCR reaction: prepare reaction system in PCR tube: 10 μl of commercial Taq enzyme PCRMix (2x), 0.8 μl of primer X, 0.8 μl of primer 1, 0.5 μl of probe 1, the mutation diluted in (1) Type plasmid / diluted wild-type plasmid in (1) / water 1μl, cDNA extracted from HL60 cell line 1uL, make up to 20μl with sterilized deionized water;

[0136] Wherein, primer X is the corresponding primer (SEQ ID No.2~6) when detecting different mutant plasmids, the concentration is 4~8pmol / μl, and the concentration of primer 1 (SEQ ID No.7) is 4~8pmol / μl, The concentration of probe 1 ...

Embodiment 3

[0147] Embodiment 3 utilizes mixed primer to detect fifteen kinds of mutants

[0148] grouping:

[0149] Experimental group: 15 mutated plasmids constructed in Example 1;

[0150] The negative control is wild-type NPM1; the blank control is water.

[0151] (1) Plasmid dilution: Dilute wild-type (WT), typeA, typeB, typeD, typeDD1, typeE, typeF, typeG, typeH, typeI, typeJ, typeK, typeL, typeM, typeN, typeO mutant NPM1 plasmids to 5 Gradients: 2.7x10 5 copies / uL, 2.7x10 4 copies / uL, 2.7x10 3 copies / uL, 2.7x10 2 copies / uL, 2.7x10 2 copies / uL, 2.7x10 1 copies / uL.

[0152] (2) Real-time PCR reaction: prepare reaction system in PCR tube: commercial Taq enzyme PCRMix (2x) 10 μl, primer mixture 1.6 μl, probe 1 0.5 μl, template cDNA / negative control reagent / positive control reagent 2 μl, Make up to 20μl with sterilized deionized water;

[0153] The above-mentioned primer mixture contains the above-mentioned 6 specific primers (SEQ ID No.7, SEQ ID No.2-6), wherein the concentra...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of biology, in particular to a primer, a primer combination, a test kit and an application of the primer. Various primer combinations are utilized for detecting out at least 15 types of NPM1 mutations once in a specific way at the cDNA level through a real-time quantitative PCR system, are applied to detection of minimal residual diseases after AML treatment and can also be used for identifying wNPM1 mutation for first-visit patients.

Description

technical field [0001] The invention relates to the field of biotechnology, in particular to primers, primer combinations, kits and applications thereof. Background technique [0002] Minimal residual disease (MRD) refers to submicroscopic lesions that still exist in the body without clinical symptoms after hematological tumors have achieved histomorphological remission after treatment. At present, PCR and flow cytometry are mostly used for clinical detection. [0003] Acute myeloid leukemia (AML) is the largest type of adult leukemia, accounting for about 50%-70%, and is an important fatal disease. In recent years, with the continuous improvement of treatment methods, the proportion of patients with morphological remission is increasing, but most patients still relapse after remission. Knowing the presence or absence of tumor cells in patients who achieve microscopic morphologic remission, and thus the need for further treatment, is a critical step in preventing relapse. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & AuthorityPatents(China)
IPC IPC(8): C12Q1/6886C12Q1/686C12N15/11
CPCC12Q1/686C12Q1/6886C12Q2600/156C12Q2561/113C12Q2563/107C12Q2545/114
Inventor王阳刘进马冉冉崔欢喜任用
OwnerNANJING SIMCERE MEDICAL LAB CO LTD